Join the 'Pristiq' group to help and get support from people like you.

Pristiq Blog

7 out of 10 Americans Take a Prescription Drug: Study

Posted 27 Jun 2013 by Drugs.com

THURSDAY, June 27 – Nearly 70 percent of Americans take prescription drugs, with antibiotics, antidepressants and painkillers being the most widely used, according to a new study. Researchers also found that more than half of patients take two prescription drugs, while 20 percent take five or more prescription medications. One other key finding: "As you get older you tend to get more prescriptions, and women tend to get more prescriptions than men," study author Dr. Jennifer St. Sauver, of the Mayo Clinic Center for the Science of Health Care Delivery, said in a Mayo news release. The findings come from an analysis of 2009 statistics from people living in Olmsted County, Minn., near the Mayo Clinic. St. Sauver believes the findings are comparable to people living elsewhere in the United States. According to the study, 17 percent of patients took antibiotics, 13 percent took ... Read more

Related support groups: Suboxone, Oxycodone, Methadone, Lexapro, Zoloft, Cymbalta, Hydrocodone, OxyContin, Vicodin, Effexor, Prozac, Morphine, Celexa, Norco, Fentanyl, Paxil, Lortab, Citalopram, Codeine, Opana

Ranbaxy to Market Desvenlafaxine Base Extended Release Tablets in the U.S.

Posted 6 Mar 2013 by Drugs.com

PRINCETON, N.J., March 5, 2013 /PRNewswire/ – Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that it has entered into an in-licensing agreement with Alembic Pharmaceuticals Limited to exclusively market Desvenlafaxine Base Extended Release Tablets in the U.S. healthcare system. Alembic Pharmaceuticals Limited is the sponsor and manufacturer of the New Drug Application (NDA) Desvenlafaxine Base Extended Release Tablets. The product is a bioequivalent version of innovator drug, Pristiq® by Pfizer, Inc.* The market size for Pristiq® is U.S. $ 590 Mn (IMS – MAT January 2013). Desvenlafaxine Base Extended Release Tablets is indicated for the treatment of major depressive disorder. The product will be available in 50 mg and 100 mg dosage strengths. Alembic has received the final approval from the U.S. Food and Drug Adm ... Read more

Related support groups: Pristiq, Desvenlafaxine

Psychiatric Drugs More Often Prescribed in the South

Posted 1 Feb 2013 by Drugs.com

FRIDAY, Feb. 1 – Use of psychiatric medications is most prevalent in the southern United States and least prevalent in the West, according to a new U.S. study. Although people living in the West are the least likely to use antipsychotics, antidepressants and stimulants, the Yale researchers found that the drugs' use is 40 percent higher in a large section of the South than in other parts of the country. The study authors attributed this discrepancy to variations in local access to health care and marketing efforts within the pharmaceutical industry. "The geographic patterns we identify are striking and map onto the patterns found for a host of other medical conditions and treatments, from cognitive decline to bypass surgery," Marissa King, assistant professor of organizational behavior at the Yale School of Management, said in a school news release. "Our work suggests that access to ... Read more

Related support groups: Depression, Bipolar Disorder, Lexapro, Adderall, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Seroquel, Celexa, Paxil, Phentermine, Trazodone, Vyvanse, Citalopram, Abilify, Pristiq, Lithium, Viibryd

Newer Antidepressants May Be Safe for Parkinson's Patients

Posted 11 Apr 2012 by Drugs.com

WEDNESDAY, April 11 – Some of the newer antidepressants can help treat depression in people with Parkinson's disease without aggravating other disease symptoms such as tremor or rigidity, researchers have found. Nearly 1 million people in the United States are living with Parkinson's disease, a progressive movement disorder marked by tremor, slowness and/or rigidity. Parkinson's disease and depression tend to travel together, and there has been concern that some of the medications used to treat depression may worsen motor symptoms. A new study published online April 11 and in the April 17 print issue of Neurology shows that this is not the case, at least when it comes to the antidepressants Paxil (paroxetine) and Effexor (venlafaxine). Paxil is in the class of drugs known as SSRIs (selective serotonin reuptake inhibitors) while Effexor is an SNRI (serotonin and norepinephrine reuptake ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Effexor, Prozac, Celexa, Paxil, Citalopram, Pristiq, Sertraline, Effexor XR, Fluoxetine, Venlafaxine, Savella, Parkinson's Disease, Escitalopram, Paroxetine, Luvox, Duloxetine

Minorities, Medicare Recipients Less Likely to Get Antidepressants

Posted 9 Apr 2012 by Drugs.com

MONDAY, April 9 – Hispanics and blacks are less likely to be prescribed antidepressants than whites, and Medicare and Medicaid patients are less likely to receive the drugs than those with private insurance, a new study says. University of Michigan School of Public Health researchers examined data from 1993 to 2007 and found that whites were 1.5 times more likely to receive antidepressants than blacks or Hispanics with major depression. The study also found that Medicare and Medicaid patients were 31 percent and 38 percent less likely to be prescribed antidepressants than privately insured patients. Race didn't play a role in the type of antidepressants prescribed to patients, but insurance did. Medicare and Medicaid patients were 58 percent and 61 percent less likely to receive newer antidepressants than privately insured patients. Newer types of antidepressants such as serotonin ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Viibryd, Amitriptyline, Sertraline, Bupropion, Effexor XR, Fluoxetine, Venlafaxine, Savella

Best Antidepressant May Depend on Patient: Study

Posted 5 Dec 2011 by Drugs.com

TBD – Newer antidepressants seem to be about as effective as one another, a new analysis indicates. This suggests that the choice of which drug is appropriate for which patient should be made on the basis of such considerations as side effects, cost and patient preference. "They're all equally effective," said Dr. David Schlager, a clinical assistant professor of psychiatry and behavioral science at Texas A&M Health Science Center College of Medicine. "They're interchangeable except for side effects," he added, so psychiatrists do tend to "exploit the side-effect profile" to find suitable medications for individual patients, he added. According to the background information in the new study, appearing in the Dec. 6 issue of Annals of Internal Medicine, some 27 million people in the United States had taken antidepressants as of 2005. Most of these drugs are "second-generation" ... Read more

Related support groups: Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Citalopram, Pristiq, Sertraline, Bupropion, Effexor XR, Fluoxetine, Venlafaxine, Savella, Wellbutrin XL, Wellbutrin SR, Escitalopram, Paroxetine

Fear of Antidepressants Keep Many From Disclosing Depression

Posted 13 Sep 2011 by Drugs.com

TUESDAY, Sept. 13 – For a nation that seems ready to pop a pill for any ill, a new study suggests that the opposite seems true for some people with symptoms of depression, whose concerns about the side effects of antidepressants were the top reason they wouldn't disclose warning signs to their doctors. A phone survey of more than 1,000 adults who had previously participated in the California Behavioral Risk Factor Survey System, which probed depression-related beliefs, showed that 43 percent reported one or more reasons for not talking to their primary care physician about their depression. Nearly a quarter of them worried that their doctor would recommend antidepressants – the most frequently cited reason for withholding the information. Other stated barriers to sharing depressive symptoms included the belief that it's not a primary care physician's job to deal with emotional issues ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Viibryd, Amitriptyline, Sertraline, Bupropion, Effexor XR, Fluoxetine, Venlafaxine, Savella

Certain Antidepressants Linked to Falls in Nursing Homes

Posted 26 Jul 2011 by Drugs.com

TUESDAY, July 26 – In the days after they start taking non-SSRI (selective serotonin reuptake inhibitor) antidepressants, such as bupropion or venlafaxine, nursing home residents are at significantly greater risk for falls, according to a new study. Researchers found the increased risk for falls also applies to those who had a dosage increase of their current prescription. "Our results identify the days following a new prescription or increased dose of a non-SSRI antidepressant as a window of time associated with a particularly high risk of falling among nursing home residents," said study author Dr. Sarah D. Berry, a scientist at the Institute for Aging Research of Hebrew SeniorLife in Boston. More closely monitoring these nursing home residents for two days after a change in these antidepressants could help prevent falls, the researchers said. In conducting the study, recently ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Citalopram, Pristiq, Sertraline, Bupropion, Effexor XR, Fluoxetine, Venlafaxine, Savella, Wellbutrin XL, Wellbutrin SR, Escitalopram

Antidepressant Use Rising as Psychotherapy Rates Fall

Posted 6 Dec 2010 by Drugs.com

MONDAY, Dec. 6 – Even as fewer Americans have sought psychotherapy for their depression, antidepressant prescription rates have continued to climb in recent years, a new survey reveals. "This is an encouraging trend as it suggests that fewer depressed Americans are going without treatment," said study author Dr. Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. "At the same time, however, the decline in psychotherapy raises the possibility that many depressed patients are not receiving optimal care." "While progress is being made in increasing the availability of depression care, a mismatch is opening up between clinical evidence and practice," Olfson cautioned. "For many depressed adults and youth, a combination of psychotherapy and antidepressants is the most effective approach. Yet, only about one-third of ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Amitriptyline, Sertraline, Bupropion, Effexor XR, Fluoxetine, Venlafaxine, Savella, Mirtazapine

Antidepressant Use in U.S. Has Almost Doubled

Posted 16 Dec 2009 by Drugs.com

MONDAY, Aug. 3 – Antidepressant use among United States residents almost doubled between 1996 and 2005, along with a concurrent rise in the use of other psychotropic medications, a new report shows. The increase seemed to span virtually all demographic groups. "Over 10 percent of people over the age of 6 were receiving anti-depression medication. That strikes me as significant," said study author Dr. Mark Olfson, a professor of clinical psychiatry at Columbia University/New York State Psychiatric Institute in New York City. According to background information in the study, antidepressants are now the most widely prescribed class of drugs in the United States. The expansion in use dates back to the 1980s, with the introduction of the antidepressant Prozac (fluoxetine). The study found that 5.84 percent of U.S. residents aged 6 and over were using antidepressants in 1996, compared with ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Trazodone, Citalopram, Pristiq, Amitriptyline, Sertraline, Bupropion, Effexor XR, Fluoxetine, Venlafaxine, Savella, Mirtazapine

Psych Drugs Gaining Widespread Acceptance

Posted 16 Dec 2009 by Drugs.com

FRIDAY, July 31 – A growing number of Americans now have a positive opinion on psychiatric medications, a new study contends. About five out of six people surveyed felt psychiatric medications could help people control psychiatric symptoms, but many also expected the medications could help people deal with day-to-day stresses, help them feel better about themselves and make things easier with family and friends. "People's attitudes regarding psychiatric medications became more favorable between 1998 and 2006," said study author Dr. Ramin Mojtabai, an associate professor in the department of mental health at Johns Hopkins Bloomberg School of Public Health in Baltimore. Mojtabai expressed concern, however, that people's attitudes were increasingly positive, even in situations where there might not be a proven benefit to the drugs. "My hope would be for people to be more discriminating in ... Read more

Related support groups: Anxiety, Depression, Generalized Anxiety Disorder, Panic Disorder, Bipolar Disorder, Insomnia, Anxiety and Stress, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Celexa, Paxil, Obsessive Compulsive Disorder, Trazodone, Citalopram, Pristiq, Social Anxiety Disorder

Psychotropic Medications Associated With Risk of Falls in Older Adults

Posted 1 Dec 2009 by Drugs.com

CHICAGO, Nov. 23, 2009 - Older adults who take several types of psychotropic medications—such as antidepressants or sedatives—appear more likely to experience falls, according to an analysis of previous studies reported in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. More than 30 percent of individuals older than 65 will fall at least once a year, and falls and their complications are the fifth-leading cause of death in the developed world, according to background information in the article. Each year, 85 percent of all injury-related hospital admissions and more than 40 percent of nursing home admissions are related to falls, and the annual costs related to falls and their complications are estimated to be in the billions of dollars worldwide. Both internal and external risk factors contribute to falls, and medications have previously been i ... Read more

Related support groups: Xanax, Lexapro, Zoloft, Cymbalta, Wellbutrin, Effexor, Prozac, Klonopin, Celexa, Paxil, Clonazepam, Trazodone, Ambien, Valium, Ativan, Citalopram, Pristiq, Amitriptyline, Sertraline, Alprazolam

Ask a Question

Further Information

Related Condition Support Groups

Major Depressive Disorder, Depression

Pristiq Patient Information at Drugs.com